QuantiFERON TB gold: A new method for latent tuberculosis infection

Alessandra Bua, Paola Molicotti, Giovanni Delogu, Piero Pirina, Maria Stella Mura, Giordano Madeddu, Franca F. Saba, Ivana Maida, Leonardo A. Sechi, Stefania Zanetti

Research output: Contribution to journalArticlepeer-review


QuantiFERON-TB Gold obtained approval in 2003 by the Food and Drug Administration as a valid tool for the diagnosis of latent tuberculosis. In this report, we evaluated its potential use in the immunological diagnosis of Mycobacterium tuberculosis infections in different groups of subjects. Our data indicate that QuantiFERON-TB Gold is specific for identifying subjects who have come into contact with M. tuberculosis and its use alongside traditional diagnostic techniques may be an important instrument for controlling tuberculosis.

Original languageEnglish
Pages (from-to)477-480
Number of pages4
JournalNew Microbiologica
Issue number4
Publication statusPublished - Oct 2007


  • CFP-10
  • Esat-6
  • Immunity
  • Quantiferon-TB gold
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology


Dive into the research topics of 'QuantiFERON TB gold: A new method for latent tuberculosis infection'. Together they form a unique fingerprint.

Cite this